| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥867.8B | ¥767.7B | +13.0% |
| Operating Income | ¥29.4B | ¥26.1B | +12.7% |
| Ordinary Income | ¥30.5B | ¥27.2B | +12.0% |
| Net Income | ¥21.1B | ¥18.1B | +16.5% |
| ROE | 6.7% | 5.9% | - |
FY2026 Q3 cumulative results show revenue of 86.8B yen (YoY +13.0%), operating income of 2.9B yen (+12.7%), ordinary income of 3.1B yen (+12.0%), and net income of 2.1B yen (+16.5%). The company achieved double-digit revenue growth driven by expansion across all geographic segments, particularly strong performance in China where sales increased 51.0% YoY. Operating margin remained at 3.4%, consistent with prior year levels, while net profit margin improved to 2.4% from 2.4% YoY. Total assets decreased to 699.7B yen from 741.5B yen, primarily due to a 37.3% reduction in cash and deposits, while total equity increased 2.1% to 313.3B yen, resulting in an equity ratio of 44.8%.
Revenue growth of 13.0% was driven by broad-based expansion across all geographic segments and product categories. The Japan segment recorded sales of 70.3B yen (+6.8% YoY), while China demonstrated exceptional growth with sales of 14.7B yen (+51.0% YoY), recovering from a prior-year loss position to achieve operating income of 293M yen. The Other segment contributed 6.0B yen in external sales. By product category, electronic measuring instruments grew to 31.8B yen from 30.1B yen, manufacturing and inspection equipment increased to 10.3B yen from 8.2B yen, and electronic components expanded to 14.6B yen from 12.7B yen. The China segment's turnaround from an operating loss of 88M yen to a profit of 293M yen represents a significant improvement in profitability structure.
On the profit side, gross profit increased to 12.1B yen with a gross margin of 14.0%, maintaining stable profitability despite revenue expansion. Selling, general and administrative expenses totaled 9.2B yen, increasing proportionally with revenue growth but maintaining operating leverage. Operating income reached 2.9B yen with an operating margin of 3.4%, consistent with the prior year's 3.4%. Non-operating income contributed positively with foreign exchange gains of 95M yen, dividend income of 42M yen, and interest income of 20M yen. Extraordinary income included investment securities sale gains of 77M yen. The progression from operating income of 2.9B yen to ordinary income of 3.1B yen reflects a net non-operating contribution of approximately 110M yen, representing 1.3% of revenue. Net income of 2.1B yen represents a 16.5% increase, supported by both operating performance and effective tax management. This represents a revenue up, profit up pattern, with broad-based geographic and product expansion driving sustainable top-line growth while maintaining operational efficiency.
The Japan segment represents the core business with sales of 70.3B yen (82.6% of total) and operating income of 3.9B yen, delivering an operating margin of 5.5%. Sales increased 6.8% YoY while operating profit grew 5.0%, indicating stable profitability in the domestic market. The China segment recorded sales of 14.7B yen (17.3% of total) with operating income of 293M yen, achieving a dramatic turnaround from the prior year's operating loss of 88M yen. This represents an operating margin of 2.0%, marking significant progress toward profitability normalization. The Other segment contributed 6.0B yen in external sales with operating income of 449M yen, maintaining a stable operating margin of 7.5%. After adjustments for inter-segment eliminations of 2M yen, inventory adjustments of 10M yen, and corporate expenses of 1.7B yen, consolidated operating income totaled 2.9B yen. The margin differential between segments is material, with the Other segment demonstrating superior profitability at 7.5% compared to Japan's 5.5% and China's 2.0%, suggesting opportunities for margin improvement through geographic mix optimization and operational efficiency enhancements in emerging markets.
[Profitability] ROE of 6.7% improved from prior levels but remains below industry standards, with net profit margin of 2.4% and operating margin of 3.4% reflecting the trading industry's characteristically thin margin structure. The DuPont analysis reveals ROE is driven by asset turnover of 1.240x and financial leverage of 2.23x, while profit margin contribution remains limited. ROIC of 4.7% indicates room for improvement in capital efficiency. [Cash Quality] Cash and deposits of 64.3B yen decreased 37.3% YoY, providing 0.46x coverage of short-term borrowings of 140.7B yen, indicating heightened liquidity management requirements. Interest coverage ratio of 23.06x demonstrates strong debt servicing capability. [Investment Efficiency] Asset turnover of 1.240x improved from prior periods as revenue growth outpaced asset base expansion. Days sales outstanding extended to 147 days, reflecting lengthened collection cycles that warrant monitoring. Inventory days increased substantially as inventory rose 44.9% to 80.4B yen. [Financial Health] Equity ratio of 44.8% decreased from 41.4% as asset base contracted faster than equity growth. Current ratio of 176.7% and quick ratio of 153.7% indicate adequate short-term liquidity, though the ratio of current liabilities to total liabilities of 82.5% suggests concentration in near-term obligations. Debt-to-equity ratio of 1.23x remains moderate, with net debt-to-EBITDA positioning requiring careful monitoring given the short-term debt concentration.
Cash and deposits decreased 38.3B yen YoY to 64.3B yen, representing a 37.3% reduction that reflects significant changes in working capital structure. The decline in cash occurred alongside a 44.9% increase in inventory to 80.4B yen (up 24.9B yen), suggesting cash deployment into inventory buildup to support revenue expansion and anticipated demand. Accounts receivable increased to 349.0B yen, with DSO extending to 147 days indicating slower collection velocity. On the liability side, accounts payable decreased 64.7B yen to 149.1B yen (down 30.3%), representing a reversal in trade credit utilization and contributing to cash outflow. Short-term borrowings of 140.7B yen provide 2.19x coverage of the reduced cash position, though the cash-to-short-term-debt ratio of 0.46x indicates elevated refinancing requirements. The combined effect of inventory accumulation, payables reduction, and cash drawdown suggests operating cash generation was pressured by working capital expansion. The company maintains adequate liquidity buffers with current ratio of 176.7x and has demonstrated debt servicing strength with interest coverage of 23.06x, though the structural shift toward higher inventory and lower payables warrants attention to cash conversion cycle optimization.
Ordinary income of 3.1B yen compared to operating income of 2.9B yen reflects a net non-operating contribution of approximately 110M yen, representing 1.3% of revenue. The primary components include foreign exchange gains of 95M yen, dividend income of 42M yen, and interest income of 20M yen, partially offset by interest expenses. Non-operating income represents a modest enhancement to operating performance and consists largely of financial income and FX gains that can fluctuate with market conditions. Extraordinary income included investment securities sale gains of 77M yen, which should be viewed as non-recurring in nature. The progression from ordinary income to net income reflects effective tax management with a normalized tax burden. The extension of DSO to 147 days and the 44.9% increase in inventory raise considerations about working capital quality and potential accruals accumulation. While cash flow statement data is not available for this quarterly period, the balance sheet movements show cash declining 37.3% while inventory and receivables expanded significantly, suggesting operating cash generation lagged accounting earnings. The disconnect between strong reported profit growth of 16.5% and deteriorating cash position indicates earnings quality warrants monitoring, particularly regarding the timing and realizability of revenue recognition given the extended collection periods and inventory buildup.
Full-year guidance targets revenue of 124.0B yen, operating income of 4.5B yen, ordinary income of 4.5B yen, and net income of 3.0B yen with EPS of 265.29 yen. Q3 cumulative results show revenue progress of 70.0% (86.8B yen vs 124.0B yen target), operating income progress of 65.4% (2.9B yen vs 4.5B yen target), and net income progress of 69.6% (2.1B yen vs 3.0B yen target). Against standard quarterly progress expectations of 75% by Q3, revenue is tracking 5.0 percentage points below, operating income is 9.6 percentage points below, and net income is 5.4 percentage points below the standard benchmark. This suggests Q4 will require disproportionate contribution to achieve full-year targets, with an implied Q4 operating income of 1.6B yen needed to reach guidance. The full-year revenue growth guidance of 2.3% YoY and operating income decline guidance of 5.0% YoY represent a deceleration from the 13.0% revenue growth and 12.7% operating income growth achieved in Q3 cumulative, indicating expected normalization or headwinds in Q4. The company forecasts an annual dividend of 47 yen per share. The below-standard progress rates across key metrics, particularly in operating income, suggest either conservative full-year planning or anticipated Q4 pressures that warrant close monitoring of order intake trends and margin sustainability.
The company paid an interim dividend of 40 yen per share in Q2 and forecasts a full-year dividend of 47 yen per share. Based on forecasted net income of 3.0B yen and assuming the full-year dividend applies to the outstanding share base, the calculated payout ratio is approximately 49.2%, within a sustainable range for dividend maintenance. Comparing to Q3 cumulative net income of 2.1B yen, the dividend policy reflects a balanced approach to shareholder returns while preserving capital for working capital needs and business investment. No share buyback activity has been disclosed in the available data. The dividend policy appears sustainable given the sub-60% payout ratio, though the 37.3% decline in cash reserves and elevated working capital requirements suggest the company is managing competing demands for cash deployment. The total return ratio equals the payout ratio of 49.2% in the absence of buybacks. Given the liquidity dynamics observed in the balance sheet, with cash coverage of short-term debt at 0.46x and significant inventory buildup, the company appears to be prioritizing operational funding needs while maintaining dividend commitments at current levels.
Working capital deterioration risk: Inventory increased 44.9% to 80.4B yen while DSO extended to 147 days, significantly above the industry median of 74 days for receivables and 51 days for inventory. The combined working capital cycle expansion ties up 24.9B yen in inventory and extends cash collection periods, creating potential for obsolescence, valuation adjustments, and collection difficulties if demand softens or customer financial conditions weaken.
Short-term liquidity and refinancing risk: Cash declined 37.3% to 64.3B yen while short-term borrowings stand at 140.7B yen, resulting in cash coverage of only 0.46x. With 82.5% of total liabilities classified as current, the company faces concentrated near-term repayment obligations. Any disruption to credit facility renewals or tightening of lending conditions could create refinancing pressure.
Margin compression risk: Operating margin of 3.4% and gross margin of 14.0% remain at the lower end of historical ranges and below desired efficiency thresholds. The company faces EBIT margin below 5% warning levels. With SG&A expenses of 9.2B yen growing alongside revenue, any revenue shortfall or pricing pressure in competitive trading markets could quickly erode the thin profit margins. The China segment's recent return to profitability at 2.0% margin remains fragile and susceptible to demand volatility or cost inflation.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: The company's net profit margin of 2.4% aligns with the trading industry median of 2.0% (IQR: 1.0%-3.9%, n=15), while operating margin of 3.4% slightly exceeds the industry median of 3.2% (IQR: 1.3%-4.6%, n=15). ROE of 6.7% surpasses the industry median of 3.7% (IQR: 2.2%-8.4%, n=15), positioning in the upper quartile. However, ROIC of 4.7% falls near the industry median of 3.0% (IQR: 1.0%-16.0%, n=15), indicating comparable capital efficiency challenges across the sector.
Growth: Revenue growth of 13.0% YoY substantially exceeds the industry median of 2.6% (IQR: -5.3%-10.8%, n=15), placing the company among top-quartile performers in top-line expansion. EPS growth also outperforms relative to the industry median of 0.31 (IQR: -0.06-1.97, n=15).
Financial Health: Equity ratio of 44.8% falls slightly below the industry median of 47.8% (IQR: 43.0%-55.5%, n=15), indicating comparable leverage positioning. Current ratio of 176.7% is below the industry median of 188.0% (IQR: 164.0%-238.0%, n=15), though still within healthy ranges. Financial leverage of 2.23x exceeds the industry median of 1.97x (IQR: 1.80-2.33, n=15), reflecting slightly more aggressive capital structure.
Efficiency: Asset turnover of 1.240x exceeds the industry median of 1.06x (IQR: 0.70-1.32, n=15), demonstrating superior asset utilization. However, receivables turnover of 147 days significantly exceeds the industry median of 74 days (IQR: 65-91 days, n=15), indicating collection efficiency warrants improvement. Inventory turnover also lags with current inventory days substantially above the industry median of 51 days (IQR: 31-75 days, n=13). Operating working capital cycle efficiency requires attention relative to peer performance.
(Industry: Trading sector, N=15 companies, Comparison: 2025-Q3 median values, Source: Proprietary analysis)
Revenue momentum significantly outpaces industry with 13.0% growth versus sector median of 2.6%, driven by strong execution in China (51.0% growth) and successful market share gains across product categories. The company demonstrates top-quartile growth characteristics while maintaining operating margins in line with sector norms, indicating effective scaling without material margin sacrifice. This growth trajectory positions the company favorably for continued market penetration, particularly in the recovering China market where the segment returned to profitability.
Working capital management emerges as a critical focus area, with inventory increasing 44.9% and DSO extending to 147 days, both significantly exceeding industry benchmarks of 51 days for inventory and 74 days for receivables. The simultaneous 37.3% decline in cash to 64.3B yen and reduction in payables by 30.3% creates a structural shift in liquidity profile. While current and quick ratios remain adequate, the cash coverage of short-term debt at 0.46x and elevated working capital absorption signal the need for enhanced cash conversion cycle management to support growth without liquidity strain.
Capital efficiency metrics present mixed signals: ROE of 6.7% exceeds industry median of 3.7%, supported by above-average asset turnover of 1.24x versus industry median of 1.06x. However, ROIC of 4.7% remains in the modest range, and the thin operating margin of 3.4% leaves limited buffer for operational pressures. The full-year guidance implies Q4 deceleration with operating income expected to decline 5.0% YoY despite Q3 cumulative growth of 12.7%, suggesting management anticipates normalization or headwinds. The below-standard progress rates toward full-year targets indicate Q4 execution will be determinative of meeting guidance, warranting attention to order flow and margin sustainability in the final quarter.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.